# Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

> **NCT07163260** · — · ENROLLING_BY_INVITATION · sponsor: **Novo Nordisk A/S** · enrollment: 244 (estimated)

## Conditions studied

- Haemophilia

## Interventions

- **OTHER:** No treatment given

## Key facts

- **NCT ID:** NCT07163260
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-01-31
- **Primary completion:** 2025-12-19
- **Final completion:** 2025-12-19
- **Target enrollment:** 244 (ESTIMATED)
- **Last updated:** 2025-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07163260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07163260, "Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07163260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*